# Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft

> **NCT01688648** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 160 (actual)

## Conditions studied

- Unstable Angina
- Coronary Artery Bypass Graft
- Dexmedetomidine
- Lidocaine
- Myocardial Injury
- Arrhythmia
- Blood Electrolyte Balance

## Interventions

- **DRUG:** Lidocaine infusion
- **DRUG:** Dexmedetomidine infusion

## Key facts

- **NCT ID:** NCT01688648
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2014-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688648, "Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01688648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*